AXS Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,802
| Closed | -$1.43M | – | 146 |
|
|
2025
Q1 | $1.43M | Sell |
6,802
-1,342
| -16% | -$281K | 0.39% | 93 |
|
|
2024
Q4 | $1.45M | Buy |
8,144
+904
| +12% | +$161K | 0.4% | 92 |
|
|
2024
Q3 | $1.43M | Sell |
7,240
-879
| -11% | -$174K | 0.38% | 113 |
|
|
2024
Q2 | $1.39M | Buy |
8,119
+345
| +4% | +$59.2K | 0.39% | 90 |
|
|
2024
Q1 | $1.42M | Sell |
7,774
-1,756
| -18% | -$320K | 0.34% | 91 |
|
|
2023
Q4 | $1.48M | Buy |
9,530
+307
| +3% | +$47.6K | 0.35% | 81 |
|
|
2023
Q3 | $1.37M | Buy |
9,223
+8,115
| +732% | +$1.21M | 0.35% | 78 |
|
|
2023
Q2 | $149K | Sell |
1,108
-230
| -17% | -$31K | 0.04% | 280 |
|
|
2023
Q1 | $213K | Buy |
1,338
+217
| +19% | +$34.6K | 0.07% | 209 |
|
|
2022
Q4 | $181K | Buy |
+1,121
| New | +$181K | 0.06% | 200 |
|
|
2022
Q3 | – | Sell |
-1,813
| Closed | -$278K | – | 203 |
|
|
2022
Q2 | $278K | Sell |
1,813
-595
| -25% | -$91.2K | 0.1% | 190 |
|
|
2022
Q1 | $390K | Sell |
2,408
-1,627
| -40% | -$264K | 0.16% | 101 |
|
|
2021
Q4 | $546K | Buy |
+4,035
| New | +$546K | 0.13% | 108 |
|
|
2021
Q3 | – | Sell |
-4,628
| Closed | -$521K | – | 100 |
|
|
2021
Q2 | $521K | Buy |
4,628
+1,120
| +32% | +$126K | 0.16% | 116 |
|
|
2021
Q1 | $380K | Buy |
+3,508
| New | +$380K | 0.14% | 123 |
|